These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18541748)

  • 1. Letter by Connelly et al regarding article, "Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension".
    Connelly KA; Gilbert RE; Krum H
    Circulation; 2008 Jun; 117(23):e483; author reply e484. PubMed ID: 18541748
    [No Abstract]   [Full Text] [Related]  

  • 2. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
    Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products promote heart failure through inducing the immune maturation of dendritic cells.
    Cao W; Chen J; Chen Y; Chen X; Liu P
    Appl Biochem Biotechnol; 2014 Apr; 172(8):4062-77. PubMed ID: 24610037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
    Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
    Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation endproducts in chronic heart failure.
    Smit AJ; Hartog JW; Voors AA; van Veldhuisen DJ
    Ann N Y Acad Sci; 2008 Apr; 1126():225-30. PubMed ID: 18448821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice.
    Liu Y; Yu M; Zhang Z; Yu Y; Chen Q; Zhang W; Zhao X
    Eur J Pharmacol; 2016 Nov; 791():535-543. PubMed ID: 27393458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation products as markers and predictors of the progression of diabetic complications.
    Monnier VM; Sell DR; Genuth S
    Ann N Y Acad Sci; 2005 Jun; 1043():567-81. PubMed ID: 16037280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What mechanisms underlie diastolic dysfunction in heart failure?
    Kass DA; Bronzwaer JG; Paulus WJ
    Circ Res; 2004 Jun; 94(12):1533-42. PubMed ID: 15217918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart.
    Nozynski J; Zakliczynski M; Konecka-Mrowka D; Zakliczynska H; Pijet M; Zembala-Nozynska E; Lange D; Zembala M
    Exp Gerontol; 2013 Feb; 48(2):223-8. PubMed ID: 22982091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification.
    Li SY; Du M; Dolence EK; Fang CX; Mayer GE; Ceylan-Isik AF; LaCour KH; Yang X; Wilbert CJ; Sreejayan N; Ren J
    Aging Cell; 2005 Apr; 4(2):57-64. PubMed ID: 15771609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gigantic business: titin properties and function through thick and thin.
    Linke WA; Hamdani N
    Circ Res; 2014 Mar; 114(6):1052-68. PubMed ID: 24625729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes.
    Franssen C; Kole J; Musters R; Hamdani N; Paulus WJ
    Circ Heart Fail; 2017 Mar; 10(3):e003626. PubMed ID: 28242778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The failing cardiomyocyte.
    Harding SE
    Heart Fail Clin; 2005 Jul; 1(2):171-81. PubMed ID: 17386844
    [No Abstract]   [Full Text] [Related]  

  • 15. Do advanced glycation end products contribute to the development of long-term diabetic complications?
    Pugliese G
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):457-60. PubMed ID: 18674679
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathomechanisms in heart failure: the contractile connection.
    Stienen GJ
    J Muscle Res Cell Motil; 2015 Feb; 36(1):47-60. PubMed ID: 25376563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse remodeling of the failing human heart with mechanical unloading. Emerging concepts and unanswered questions.
    Razeghi P; Myers TJ; Frazier OH; Taegtmeyer H
    Cardiology; 2002; 98(4):167-74. PubMed ID: 12566644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of exercise and metabolism in heart failure with normal ejection fraction.
    Marwick TH; Wong CY
    Prog Cardiovasc Dis; 2007; 49(4):263-74. PubMed ID: 17185114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.
    Hartog JW; Voors AA; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur J Heart Fail; 2007 Dec; 9(12):1146-55. PubMed ID: 18023248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-extubation pulmonary edema after open cholecystectomy: significance of diastolic cardiac dysfunction.
    Sethi S; Arya VK; Chauhan S
    Ann Card Anaesth; 2011; 14(2):156-8. PubMed ID: 21636942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.